MiNK Therapeutics Inc. (NASDAQ: INKT)
$0.6910
+0.0010 ( +0.15% ) 22.9K
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Market Data
Open
$0.6910
Previous close
$0.6901
Volume
22.9K
Market cap
$27.29M
Day range
$0.6800 - $0.7100
52 week range
$0.5700 - $1.9000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 30, 2024 |
| def | Proxies and info statements | 3 | Apr 29, 2024 |
| 10-k | Annual reports | 71 | Mar 21, 2024 |
| 8-k | 8K-related | 15 | Mar 21, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Mar 05, 2024 |
| 8-k | 8K-related | 12 | Feb 29, 2024 |
| 8-k | 8K-related | 12 | Feb 14, 2024 |